Laura Wilson

机构：Ifakara Health Institute, Johns Hopkins University, Johns Hopkins Medicine, Great Ormond Street Hospital, Johns Hopkins University Applied Physics Laboratory, Provision Healthcare, CRUK Lung Cancer Centre of Excellence, University College London · ORCID：0000-0002-6294-4504

发表论文 191 篇 · 总被引 11842 次 · h-index 52

代表论文

• Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study (2023 · Gastroenterology · 被引 184)
• Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD (2024 · Journal of Hepatology · 被引 87)
• Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States (2023 · Alimentary Pharmacology & Therapeutics · 被引 67)
• Artificial Intelligence in Congenital Heart Disease (2022 · JACC Advances · 被引 61)
• PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease (2024 · Hepatology · 被引 39)
• Liver stiffness progression in biopsy-proven metabolic dysfunction–associated steatotic disease among people with diabetes versus people without diabetes: A prospective multicenter study (2024 · Hepatology · 被引 31)